trial · primary record
MTBVAC
HIV I Infection
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 276 |
| Primary completion | 2027-11 |
| Primary endpoint | Number of unsolicited adverse events |
| Registry ID | NCT05947890 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:37.218Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05947890
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Mtbvac · compound